Autologous Hematopoietic Cell Transplantation for Treatment-Refractory Relapsing Multiple Sclerosis: Position Statement from the American Society for Blood and Marrow Transplantation
Jeffrey A. Cohen(Dartmouth Health), George E. Georges(Northwestern University), Paolo A. Muraro(Imperial College Healthcare NHS Trust), Navneet S. Majhail(Sarah Cannon), Mark S. Freedman(University of Ottawa), Harold Atkins(University of Ottawa), Laura Baldassari(Cleveland Clinic), Keith M. Sullivan(Duke Medical Center), John R. Corboy(University of Colorado Denver), James D. Bowen(Swedish Medical Center), Richard A. Nash(Colorado Blood Cancer Institute), Stefanie Sarantopoulos(Duke University), Jan Storek(University of Washington), Marcelo C. Pasquini(Cleveland Clinic), Bipin N. Savani(Vanderbilt University Medical Center), Linda M. Griffith(National Institute of Allergy and Infectious Diseases), Christopher Bredeson, Robert Lowsky(Stanford Blood Center), Paul A. Carpenter(Fred Hutch Cancer Center)
Cited by 106
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Chronic graft-versus-host syndrome in man
|The American Journal of Medicine|1980|2.4k
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
|Nature Genetics|2011|2k
Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia
|New England Journal of Medicine|1986|1.5k